Jennifer Phipps - BrightSpring Health Chief Officer
| BTSG Stock | 16.96 0.80 4.50% |
Executive
Jennifer Phipps is Chief Officer of BrightSpring Health Services,
| Phone | 502 394 2100 |
| Web | https://www.brightspringhealth.com |
BrightSpring Health Management Efficiency
The company has return on total asset (ROA) of 0.037 % which means that it generated a profit of $0.037 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0181) %, meaning that it created substantial loss on money invested by shareholders. BrightSpring Health's management efficiency ratios could be used to measure how well BrightSpring Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Jeff Mason | NioCorp Developments Ltd | N/A | |
| Michelle SPHR | Olympic Steel | N/A | |
| Daniel Valenti | Jeld Wen Holding | 47 | |
| Andreas Panayiotou | Keurig Dr Pepper | N/A | |
| Colleen Penhall | Jeld Wen Holding | N/A | |
| Richard CPA | Olympic Steel | 56 | |
| Greg McDonald | SNDL Inc | N/A | |
| Poupak Bahamin | Barrick Gold Corp | 54 | |
| Cassandra Powers | Olympic Steel | N/A | |
| Jane Gelfand | Keurig Dr Pepper | N/A | |
| Nigel Dilks | Jeld Wen Holding | N/A | |
| Ed Baker | Alto Ingredients | N/A | |
| Rousseau Jooste | Barrick Gold Corp | N/A | |
| Elena BE | Western Copper and | N/A | |
| Angela Stephens | Keurig Dr Pepper | 57 | |
| Phil McBride | SNDL Inc | N/A | |
| John Steele | Barrick Gold Corp | 59 | |
| Francis Ruane | Olympic Steel | N/A | |
| James Armstrong | Jeld Wen Holding | N/A | |
| Robert Olander | Alto Ingredients | N/A | |
| Jonathan Clegg | Western Copper and | N/A | |
Management Performance
| Return On Equity | -0.0181 | ||||
| Return On Asset | 0.037 |
BrightSpring Health Leadership Team
Elected by the shareholders, the BrightSpring Health's board of directors comprises two types of representatives: BrightSpring Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BrightSpring. The board's role is to monitor BrightSpring Health's management team and ensure that shareholders' interests are well served. BrightSpring Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BrightSpring Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steven Esq, Corporate Officer | ||
| Lisa Nalley, Chief Resources | ||
| Meghan Kinnan, Senior Care | ||
| BSN CHCE, Chief Officer | ||
| Jennifer Phipps, Chief Officer | ||
| Phani Konduru, Chief Officer | ||
| William MD, Senior Affairs | ||
| Jennifer Yowler, President PharMerica | ||
| Mike McMaude, President Services | ||
| Rachael Givens, Chief Officer | ||
| Daryn Demeritt, Senior Relations | ||
| Jim Mattingly, Executive CFO | ||
| Jon Rousseau, President Chairman | ||
| Robert Barnes, President Living |
BrightSpring Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BrightSpring Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0181 | ||||
| Return On Asset | 0.037 | ||||
| Profit Margin | (0) % | ||||
| Operating Margin | 0.07 % | ||||
| Current Valuation | 5.78 B | ||||
| Shares Outstanding | 174.97 M | ||||
| Shares Owned By Insiders | 13.88 % | ||||
| Shares Owned By Institutions | 99.88 % | ||||
| Number Of Shares Shorted | 10.02 M | ||||
| Price To Book | 1.78 X |
Currently Active Assets on Macroaxis
When determining whether BrightSpring Health is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if BrightSpring Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Brightspring Health Services, Stock. Highlighted below are key reports to facilitate an investment decision about Brightspring Health Services, Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BrightSpring Health Services,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BrightSpring Health. If investors know BrightSpring will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BrightSpring Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of BrightSpring Health is measured differently than its book value, which is the value of BrightSpring that is recorded on the company's balance sheet. Investors also form their own opinion of BrightSpring Health's value that differs from its market value or its book value, called intrinsic value, which is BrightSpring Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BrightSpring Health's market value can be influenced by many factors that don't directly affect BrightSpring Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BrightSpring Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if BrightSpring Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BrightSpring Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.